(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 7.65% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Apyx Medical's revenue in 2025 is $47,902,000.On average, 6 Wall Street analysts forecast APYX's revenue for 2025 to be $1,995,845,022, with the lowest APYX revenue forecast at $1,903,796,757, and the highest APYX revenue forecast at $2,067,931,013. On average, 6 Wall Street analysts forecast APYX's revenue for 2026 to be $2,139,175,682, with the lowest APYX revenue forecast at $1,972,173,283, and the highest APYX revenue forecast at $2,328,932,015.
In 2027, APYX is forecast to generate $2,285,795,146 in revenue, with the lowest revenue forecast at $2,196,156,120 and the highest revenue forecast at $2,353,024,415.